FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151922892> ?p ?o ?g. }

• W2151922892 endingPage "107" @default.
• W2151922892 startingPage "100" @default.
• W2151922892 abstract "Programs for access to antiretroviral treatment were only recently implemented in developing countries. This study aimed to describe the effect of highly active antiretroviral therapy (HAART) in treating human immunodeficiency virus (HIV)-infected children in Thailand's National Access to Antiretroviral Program for People Living with HIV/AIDS.From August 2002 to July 2003, a total of 107 children were enrolled in the study. They received HAART consisting of either nevirapine or efavirenz, together with lamivudine and stavudine. Generic drugs and/or adult formulations were used. CD4 lymphocyte count, plasma HIV RNA level, and weight-for-age and height-for-age z scores were measured before, 2 months after, and every 6 months after initiation of HAART. A genotypic resistance assay was performed for patients with poor virological response.The mean age of the patients was 7.7 years (range, 2.1-13.8 years). At baseline, the median CD4 cell percentage was 3%, and the plasma HIV RNA level was 5.4 log10 copies/mL. Four patients died from HIV-related illness. After 72 weeks of HAART, the median CD4 cell percentage was 21%, and 76% of patients had HIV RNA levels of < 50 copies/mL. The mean weight-for-age and height-for-age z scores increased from -1.9 to -1.3 (P < .0001) and from -2.3 to -2.0 (P < .0001), respectively. The percentage of patients who took > or = 95% of prescribed medications during the interval between every follow-up visit was 86% For patients with suboptimal virological response, the most common resistance mutations among HIV isolates were associated with lamivudine and with nonnucleoside reverse-transcriptase inhibitors.In this resource-limited setting, HAART is safe and effective for HIV-infected children despite initiation of treatment during the advanced stage of disease. The use of generic and nonpediatric drug formulations is feasible." @default.
• W2151922892 created "2016-06-24" @default.
• W2151922892 creator A5003504005 @default.
• W2151922892 creator A5005634182 @default.
• W2151922892 creator A5027196977 @default.
• W2151922892 creator A5042374512 @default.
• W2151922892 creator A5051559120 @default.
• W2151922892 creator A5070044949 @default.
• W2151922892 creator A5083059000 @default.
• W2151922892 date "2005-07-01" @default.
• W2151922892 modified "2023-09-27" @default.
• W2151922892 title "Efficacy of Highly Active Antiretroviral Therapy in HIV-Infected Children Participating in Thailand's National Access to Antiretroviral Program" @default.
• W2151922892 cites W1964622370 @default.
• W2151922892 cites W1968711221 @default.
• W2151922892 cites W1990837777 @default.
• W2151922892 cites W2005617325 @default.
• W2151922892 cites W2007048368 @default.
• W2151922892 cites W2013788600 @default.
• W2151922892 cites W2020845967 @default.
• W2151922892 cites W2036564968 @default.
• W2151922892 cites W2044854544 @default.
• W2151922892 cites W2061682103 @default.
• W2151922892 cites W2065855820 @default.
• W2151922892 cites W2102133068 @default.
• W2151922892 cites W2102155948 @default.
• W2151922892 cites W2102266893 @default.
• W2151922892 cites W2117579170 @default.
• W2151922892 cites W2123087672 @default.
• W2151922892 cites W2141776019 @default.
• W2151922892 cites W2151654446 @default.
• W2151922892 cites W2318180004 @default.
• W2151922892 cites W2330042106 @default.
• W2151922892 doi "https://doi.org/10.1086/430714" @default.
• W2151922892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15937769" @default.
• W2151922892 hasPublicationYear "2005" @default.
• W2151922892 type Work @default.
• W2151922892 sameAs 2151922892 @default.
• W2151922892 citedByCount "142" @default.
• W2151922892 countsByYear W21519228922012 @default.
• W2151922892 countsByYear W21519228922013 @default.
• W2151922892 countsByYear W21519228922014 @default.
• W2151922892 countsByYear W21519228922015 @default.
• W2151922892 countsByYear W21519228922016 @default.
• W2151922892 countsByYear W21519228922017 @default.
• W2151922892 countsByYear W21519228922018 @default.
• W2151922892 countsByYear W21519228922020 @default.
• W2151922892 countsByYear W21519228922021 @default.
• W2151922892 crossrefType "journal-article" @default.
• W2151922892 hasAuthorship W2151922892A5003504005 @default.
• W2151922892 hasAuthorship W2151922892A5005634182 @default.
• W2151922892 hasAuthorship W2151922892A5027196977 @default.
• W2151922892 hasAuthorship W2151922892A5042374512 @default.
• W2151922892 hasAuthorship W2151922892A5051559120 @default.
• W2151922892 hasAuthorship W2151922892A5070044949 @default.
• W2151922892 hasAuthorship W2151922892A5083059000 @default.
• W2151922892 hasBestOaLocation W21519228921 @default.
• W2151922892 hasConcept C126322002 @default.
• W2151922892 hasConcept C142462285 @default.
• W2151922892 hasConcept C187212893 @default.
• W2151922892 hasConcept C203014093 @default.
• W2151922892 hasConcept C2522874641 @default.
• W2151922892 hasConcept C2776452011 @default.
• W2151922892 hasConcept C2777869810 @default.
• W2151922892 hasConcept C2779130552 @default.
• W2151922892 hasConcept C2779889181 @default.
• W2151922892 hasConcept C2780593183 @default.
• W2151922892 hasConcept C2780727368 @default.
• W2151922892 hasConcept C2781432083 @default.
• W2151922892 hasConcept C2993143319 @default.
• W2151922892 hasConcept C3013748606 @default.
• W2151922892 hasConcept C71924100 @default.
• W2151922892 hasConceptScore W2151922892C126322002 @default.
• W2151922892 hasConceptScore W2151922892C142462285 @default.
• W2151922892 hasConceptScore W2151922892C187212893 @default.
• W2151922892 hasConceptScore W2151922892C203014093 @default.
• W2151922892 hasConceptScore W2151922892C2522874641 @default.
• W2151922892 hasConceptScore W2151922892C2776452011 @default.
• W2151922892 hasConceptScore W2151922892C2777869810 @default.
• W2151922892 hasConceptScore W2151922892C2779130552 @default.
• W2151922892 hasConceptScore W2151922892C2779889181 @default.
• W2151922892 hasConceptScore W2151922892C2780593183 @default.
• W2151922892 hasConceptScore W2151922892C2780727368 @default.
• W2151922892 hasConceptScore W2151922892C2781432083 @default.
• W2151922892 hasConceptScore W2151922892C2993143319 @default.
• W2151922892 hasConceptScore W2151922892C3013748606 @default.
• W2151922892 hasConceptScore W2151922892C71924100 @default.
• W2151922892 hasIssue "1" @default.
• W2151922892 hasLocation W21519228921 @default.
• W2151922892 hasLocation W21519228922 @default.
• W2151922892 hasOpenAccess W2151922892 @default.
• W2151922892 hasPrimaryLocation W21519228921 @default.
• W2151922892 hasRelatedWork W1966032860 @default.
• W2151922892 hasRelatedWork W2022055721 @default.
• W2151922892 hasRelatedWork W2031198260 @default.
• W2151922892 hasRelatedWork W2128697929 @default.
• W2151922892 hasRelatedWork W2157436220 @default.
• W2151922892 hasRelatedWork W2165405202 @default.
• W2151922892 hasRelatedWork W2287123786 @default.

• next